This study develops a multiphysics framework for evaluating whether alternating magnetic fields (AMF) applied to Fe₃O₄ and MnFe₂O₄ nanoparticles can modify ATP hydrolysis through thermal, mechanical, and ion-mediated pathways. Rather than assigning a single phenomenological magnetic activation-energy reduction to all effects, the model starts from Arrhenius/Eyring kinetics and derives the observed rate change as the sum of a temperature-dependent contribution and explicitly defined non-thermal perturbations. The thermal term is constrained by the measured temperature history and nanoparticle specific absorption rate (SAR); the mechanical term is related to magnetic torque, hydrodynamic damping, and experimentally measurable particle motion; and the catalytic term is expressed through independently measurable Fe²⁺/Mn²⁺ concentrations and dose-response parameters. The available experimental observations reported in the original manuscript—2.5–3-fold enhancement of non-enzymatic hydrolysis under nanoparticle/AMF conditions, approximately 40% enhancement of Na⁺/K⁺-ATPase activity under stated isothermal conditions, and Raman/FTIR changes in phosphate-associated bands—are retained, but their interpretation is deliberately narrowed. In particular, the present data support rate enhancement under specified conditions and are consistent with multiple mechanisms; they do not, by themselves, establish a unique mechanical mechanism, nanoscale temperature gradients, or synergistic coupling. A mechanism-separation experimental matrix is therefore defined, together with quantitative spectroscopic observables and statistical requirements.
No takes yet. Share an insight, caveat, or question.
Paata J. Kervalishvili (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: